Cephalon
North America, Pennsylvania, United States, Malvern
Description
Cephalon is a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the
Investor Profile
Cephalon has backed more than 6 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 17% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series E, Corporate Round rounds (top funding stages).
- Majority of deals are located in Japan, United States.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
Stage Focus
- Series Unknown (67%)
- Series E (17%)
- Corporate Round (17%)
Country Focus
- Japan (83%)
- United States (17%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Cephalon frequently co-invest with?
Which angels does Cephalon often collaborate with?
What are some of recent deals done by Cephalon?
Find More Investors Like Cephalon
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
